Site Basel, under the lead of Prof. Dr. med. Dirk Fischer, started the recruitment process successfully on June 11th, 2018.
Site Berlin, Site Essen, Site Barcelona, Site Liverpool, Site Leeds and Site Nijmegen have successfully started with the recruitement process. Site Glasgow and Site Bruxelles have received all approvals and will soon start with the recruitement process. Site Sevilla is in the process of approval submissions.
The TAMDMD Open Label Extension is planned at all TAMDMD Sites and has already been approved at Site Basel, where the first patients entered in the Open Label Extension in June 2019.